2.46 USD
↗ 0.02 (0.82%)AT CLOSE (03:59 PM EDT)
NeuroSense Therapeutics Ltd. Ordinary Shares
NRSNNASDAQ • USD
2.57
↗ 0.11 (4.47%)
POST MARKET (AS OF 04:36 PM EDT)
Post Market
AS OF 04:36 PM EDT
2.57
↗ 0.11 (4.47%)
Market: CLOSED
NRSN is currently priced at $2.46. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 23, 2026.
Open?$2.49
High?$2.55
Low?$2.40
Prev. Close?$2.44
Volume?11.2K
Avg. Volume?N/A
VWAP?$2.49
Bid / Ask
Bid?$2.39 × 200
Ask?$3.00 × 100
Spread?$0.61
Midpoint?$2.70
Valuation & Ratios
Market Cap?4.6M
Shares Out?N/A
Float?24.7M
Float %?65.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.11%Low
Short Interest?26.9K
Days to Cover?1.2
Free Float24.7M
Avg Daily Volume22.0K
Settlement Date2026-09-30